03 · What You Need to Know
How Ongoing Consent Works During an Actual Study
There Is No Universal Ongoing-Consent Script
Ongoing consent is a principle rather than a standardized procedure performed identically in every study. A researcher conducting a single 20-minute interview has very little time between initial consent and completion. A researcher following participants for five years may encounter new findings, protocol amendments, changing circumstances, questions, declining capacity, and changes in participants' willingness to continue.
The practical approach should therefore be proportionate to the research. The Council for International Organizations of Medical Sciences (CIOMS) specifically notes that, in long-term studies, researchers should ensure participants' willingness to continue. U.S. guidance likewise treats continued consent as part of ongoing research rather than assuming that the initial decision settles every later question.
This does not mean inventing unnecessary consent procedures. More paperwork is not automatically more ethical. Sometimes it is merely more paperwork, a phenomenon research administration hardly needs additional encouragement to discover.
Routine Participation Usually Does Not Require Repeating the Entire Consent Process
Suppose a participant consented to six monthly interviews. Nothing about the study has changed, no relevant new information has emerged, and the participant arrives for the third interview knowing what it involves and appearing willing to proceed.
There is ordinarily no ethical principle requiring the researcher to reread the entire original information sheet before asking the first interview question. Depending on the approved protocol and institutional requirements, a brief confirmation that the participant is ready to continue may be sufficient.
Ongoing consent should therefore not become performative repetition. Its purpose is to protect meaningful decision-making, not to reproduce the enrollment ceremony at every encounter.
Questions Are Part of the Consent Process, Even Months Later
A participant's opportunity to ask questions should not disappear once enrollment is complete. Questions arising later may actually be more informed than those asked initially because the participant now knows what participation feels like.
If someone asks whether a procedure is optional, whether they can skip an interview, why a particular sample is needed, or whether they can stop participating, the researcher should address that question accurately rather than simply referring to the signed form.
Sometimes the question reveals a misunderstanding that matters. A participant who says, "I thought I had to finish because I signed" has misunderstood an important feature of voluntary participation. Correcting that misunderstanding is part of maintaining meaningful consent.
Participants May Need Information Repeated or Clarified
People forget information. That is hardly surprising when consent materials can contain unfamiliar terminology, multiple procedures, several study visits, and details that were not immediately relevant when the document was first read.
Forgetting a minor administrative detail does not automatically invalidate consent. The important question is whether the missing or misunderstood information matters to the participant's current decision.
If someone cannot remember the parking arrangements for the next visit, that is one problem. If someone does not remember that the next visit involves an invasive procedure, that is quite another. When a participant appears to have forgotten what they agreed to, the response should reflect the significance of what is no longer understood.
Researchers Should Pay Attention to Willingness, Not Merely Attendance
Continuing consent involves voluntariness as well as information. Researchers should therefore remain attentive to what participants communicate during the study.
An explicit "I want to stop" is straightforward. Other situations are less tidy. A participant may repeatedly hesitate, ask whether they really have to continue, resist a procedure, or appear distressed while still attending appointments.
Researchers should not diagnose reluctance from every moment of inconvenience. Research participation can be tiring or unpleasant without becoming involuntary. But neither should they treat the absence of the words "I withdraw" as permission to ignore meaningful signs that a participant may no longer wish to proceed. When someone appears uncomfortable but has not explicitly withdrawn, clarification may be necessary.
New Information May Need to Be Communicated
Research does not always remain informationally static. New safety findings may emerge. Procedures may change. Follow-up may be extended. A data breach may occur. New information about benefits, alternatives, or study burdens may become relevant.
Under the U.S. Common Rule, when appropriate, participants must be told that significant new findings developed during the research that may relate to their willingness to continue will be provided to them. FDA guidance similarly addresses significant new information that could affect continued participation in clinical investigations.
The ethical question is not simply, "Is this new?" It is closer to, "Could this information reasonably matter to the participant's decision about continuing?"
Information that does not affect current participants
A study may change administratively without altering what an enrolled participant experiences or needs to decide.
Information relevant to continued participation
A development may affect risks, burdens, procedures, alternatives, privacy, or another consideration that could reasonably matter to a participant's decision.
SACHRP, an advisory committee to the U.S. Department of Health and Human Services, has emphasized that not every change needs to be communicated to already enrolled participants. For example, a change to an eligibility criterion that has no effect on them may be irrelevant to their continuing decision.
Providing New Information Is Not Automatically the Same as Reconsenting
This distinction is particularly important in practice. Researchers may discover information that participants should receive without necessarily needing to repeat the complete consent procedure.
SACHRP distinguishes full reconsent from other ways of providing new information. Depending on the circumstances, communication might occur orally, through an information sheet or consent addendum, or through a revised consent document. FDA guidance similarly recognizes that IRBs may determine whether enrolled participants should receive new information through a revised consent form or another method.
The appropriate mechanism depends partly on the significance, complexity, and urgency of the information and the participant's stage in the research. The question of when renewed consent should actually be sought therefore goes beyond the general duty to keep participants appropriately informed.
Study Changes Should Trigger a Consent Check, Not an Automatic Conclusion
When the protocol changes, researchers should ask whether the change alters what participants were originally told or what they are now being asked to accept.
Some amendments have no meaningful effect on current participants. Others may change procedures, duration, burden, risk, expected benefits, privacy arrangements, or other matters relevant to participation.
The fact that an amendment exists does not itself answer whether participants need renewed consent. Researchers need to consider whether participants should be reconsented because of the study change and follow the determination of the relevant research ethics committee or institutional review board where applicable.
Ongoing Consent Can Become More Important in Longitudinal Research
Time creates opportunities for circumstances to diverge from those present at enrollment. Participants may forget study details. Their priorities may change. New findings may emerge. The protocol may be amended. In some populations, decision-making capacity may also change.
This does not mean researchers need a fixed reconsent schedule simply because a study lasts a long time. SACHRP has noted in the context of impaired decision-making that the frequency of any necessary reconsent procedures should fit the circumstances. What matters is whether the conditions supporting valid continuing participation remain adequate.
Ongoing Consent Must Fit the Applicable Ethics and Regulatory Framework
Specific requirements vary across jurisdictions and types of research. CIOMS states that researchers should renew informed consent when substantive changes occur in the conditions or procedures of research or when new information could affect participants' willingness to continue. U.S. regulations and guidance use somewhat different terminology and do not define "reconsent" as a regulatory term in the same way.
Researchers should therefore distinguish a general ethical principle from the specific legal or institutional procedure required for their study. The approved protocol, research ethics committee or IRB decisions, applicable regulations, sponsor requirements where relevant, and local institutional policies should determine the formal procedure.
07 · A Quick Checklist
Maintaining Consent During Research Participation
As participation continues, check:
Can participants still ask questions and receive understandable answers?
Does anyone appear to misunderstand something important about what happens next?
Has new information emerged that could reasonably affect willingness to continue?
Have study procedures, burdens, duration, risks, data uses, or other relevant conditions changed?
Are participants showing meaningful reluctance or expressing uncertainty about continuing?
Does any participant's decision-making capacity require reassessment under the approved protocol?
If new information must be communicated, has the appropriate method been determined rather than automatically defaulting to a new full consent form?
Have any required changes to consent materials or procedures received ethics committee or IRB approval before implementation, except where applicable requirements permit otherwise?
